Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Silhouette-Length-Scaled Gait Parameters for Motor Functional Analysis in Mice and Rats.

Timotius IK, Moceri S, Plank AC, Habermeyer J, Canneva F, Winkler J, Klucken J, Casadei N, Riess O, Eskofier B, von Hörsten S.

eNeuro. 2019 Nov 1;6(6). pii: ENEURO.0100-19.2019. doi: 10.1523/ENEURO.0100-19.2019. Print 2019 Nov/Dec.

2.

Systematic data analysis and data mining in CatWalk gait analysis by heat mapping exemplified in rodent models for neurodegenerative diseases.

Timotius IK, Canneva F, Minakaki G, Moceri S, Plank AC, Casadei N, Riess O, Winkler J, Klucken J, Eskofier B, von Hörsten S.

J Neurosci Methods. 2019 Oct 1;326:108367. doi: 10.1016/j.jneumeth.2019.108367. Epub 2019 Jul 24. Review.

PMID:
31351096
3.

Treadmill exercise intervention improves gait and postural control in alpha-synuclein mouse models without inducing cerebral autophagy.

Minakaki G, Canneva F, Chevessier F, Bode F, Menges S, Timotius IK, Kalinichenko LS, Meixner H, Müller CP, Eskofier BM, Casadei N, Riess O, Schröder R, Winkler J, Xiang W, von Hörsten S, Klucken J.

Behav Brain Res. 2019 May 2;363:199-215. doi: 10.1016/j.bbr.2018.11.035. Epub 2018 Dec 30.

PMID:
30599154
4.

Role of hypothalamus-pituitary-adrenal axis modulation in the stress-resilient phenotype of DPP4-deficient rats.

Golub Y, Schildbach EM, Touma C, Kratz O, Moll GH, von Hörsten S, Canneva F.

Behav Brain Res. 2019 Jan 1;356:243-249. doi: 10.1016/j.bbr.2018.08.029. Epub 2018 Aug 31.

PMID:
30176267
5.

Early postnatal behavioral, cellular, and molecular changes in models of Huntington disease are reversible by HDAC inhibition.

Siebzehnrübl FA, Raber KA, Urbach YK, Schulze-Krebs A, Canneva F, Moceri S, Habermeyer J, Achoui D, Gupta B, Steindler DA, Stephan M, Nguyen HP, Bonin M, Riess O, Bauer A, Aigner L, Couillard-Despres S, Paucar MA, Svenningsson P, Osmand A, Andreew A, Zabel C, Weiss A, Kuhn R, Moussaoui S, Blockx I, Van der Linden A, Cheong RY, Roybon L, Petersén Å, von Hörsten S.

Proc Natl Acad Sci U S A. 2018 Sep 11;115(37):E8765-E8774. doi: 10.1073/pnas.1807962115. Epub 2018 Aug 27.

6.

A dopaminergic mechanism of antipsychotic drug efficacy, failure, and failure reversal: the role of the dopamine transporter.

Amato D, Canneva F, Cumming P, Maschauer S, Groos D, Dahlmanns JK, Grömer TW, Chiofalo L, Dahlmanns M, Zheng F, Kornhuber J, Prante O, Alzheimer C, von Hörsten S, Müller CP.

Mol Psychiatry. 2018 Jul 23. doi: 10.1038/s41380-018-0114-5. [Epub ahead of print]

PMID:
30038229
7.

Dynamic footprints of α-synucleinopathic mice recorded by CatWalk gait analysis.

Timotius IK, Canneva F, Minakaki G, Pasluosta C, Moceri S, Casadei N, Riess O, Winkler J, Klucken J, von Hörsten S, Eskofier B.

Data Brief. 2018 Jan 3;17:189-193. doi: 10.1016/j.dib.2017.12.067. eCollection 2018 Apr.

8.

Early Alterations in Operant Performance and Prominent Huntingtin Aggregation in a Congenic F344 Rat Line of the Classical CAGn51trunc Model of Huntington Disease.

Plank AC, Canneva F, Raber KA, Urbach YK, Dobner J, Puchades M, Bjaalie JG, Gillmann C, Bäuerle T, Riess O, Nguyen HHP, von Hörsten S.

Front Neurosci. 2018 Jan 25;12:11. doi: 10.3389/fnins.2018.00011. eCollection 2018.

9.

Dynamic footprint based locomotion sway assessment in α-synucleinopathic mice using Fast Fourier Transform and Low Pass Filter.

Timotius IK, Canneva F, Minakaki G, Pasluosta C, Moceri S, Casadei N, Riess O, Winkler J, Klucken J, von Hörsten S, Eskofier B.

J Neurosci Methods. 2018 Feb 15;296:1-11. doi: 10.1016/j.jneumeth.2017.12.004. Epub 2017 Dec 16.

PMID:
29253577
10.

Capturing schizophrenia-like prodromal symptoms in a spinocerebellar ataxia-17 transgenic rat.

Amato D, Canneva F, Nguyen HP, Bauer P, Riess O, von Hörsten S, Müller CP.

J Psychopharmacol. 2017 Apr;31(4):461-473. doi: 10.1177/0269881116675510. Epub 2016 Nov 10.

PMID:
27856682
11.

Differential transgene expression patterns in Alzheimer mouse models revealed by novel human amyloid precursor protein-specific antibodies.

Höfling C, Morawski M, Zeitschel U, Zanier ER, Moschke K, Serdaroglu A, Canneva F, von Hörsten S, De Simoni MG, Forloni G, Jäger C, Kremmer E, Roßner S, Lichtenthaler SF, Kuhn PH.

Aging Cell. 2016 Oct;15(5):953-63. doi: 10.1111/acel.12508. Epub 2016 Jul 29.

12.

Effects of In utero environment and maternal behavior on neuroendocrine and behavioral alterations in a mouse model of prenatal trauma.

Golub Y, Canneva F, Funke R, Frey S, Distler J, von Hörsten S, Freitag CM, Kratz O, Moll GH, Solati J.

Dev Neurobiol. 2016 Nov;76(11):1254-1265. doi: 10.1002/dneu.22387. Epub 2016 Mar 9.

13.

In situ enzymatic activity of transglutaminase isoforms on brain tissue sections of rodents: A new approach to monitor differences in post-translational protein modifications during neurodegeneration.

Schulze-Krebs A, Canneva F, Schnepf R, Dobner J, Dieterich W, von Hörsten S.

Brain Res. 2016 Jan 15;1631:22-33. doi: 10.1016/j.brainres.2015.11.027. Epub 2015 Nov 23.

PMID:
26616340
14.

DPP4-deficient congenic rats display blunted stress, improved fear extinction and increased central NPY.

Canneva F, Golub Y, Distler J, Dobner J, Meyer S, von Hörsten S.

Psychoneuroendocrinology. 2015 Mar;53:195-206. doi: 10.1016/j.psyneuen.2015.01.007. Epub 2015 Jan 19.

PMID:
25635612
15.

Automated phenotyping and advanced data mining exemplified in rats transgenic for Huntington's disease.

Urbach YK, Raber KA, Canneva F, Plank AC, Andreasson T, Ponten H, Kullingsjö J, Nguyen HP, Riess O, von Hörsten S.

J Neurosci Methods. 2014 Aug 30;234:38-53. doi: 10.1016/j.jneumeth.2014.06.017. Epub 2014 Jul 11.

PMID:
25020253
16.

Glutaminyl cyclase-mediated toxicity of pyroglutamate-beta amyloid induces striatal neurodegeneration.

Becker A, Kohlmann S, Alexandru A, Jagla W, Canneva F, Bäuscher C, Cynis H, Sedlmeier R, Graubner S, Schilling S, Demuth HU, von Hörsten S.

BMC Neurosci. 2013 Oct 1;14:108. doi: 10.1186/1471-2202-14-108.

17.

Characterization of acid sphingomyelinase activity in human cerebrospinal fluid.

Mühle C, Huttner HB, Walter S, Reichel M, Canneva F, Lewczuk P, Gulbins E, Kornhuber J.

PLoS One. 2013 May 2;8(5):e62912. doi: 10.1371/journal.pone.0062912. Print 2013.

18.

Altered hypothalamic protein expression in a rat model of Huntington's disease.

Cong WN, Cai H, Wang R, Daimon CM, Maudsley S, Raber K, Canneva F, von Hörsten S, Martin B.

PLoS One. 2012;7(10):e47240. doi: 10.1371/journal.pone.0047240. Epub 2012 Oct 18. Erratum in: PLoS One. 2012;7(11). doi:10.1371/annotation/677c26e3-ce52-4837-853a-63c4ed7d72c0.

19.

[The community role of nurses with elderly people].

Canneva F.

Rev Infirm. 2012 Aug-Sep;(183):22-3. French.

PMID:
22919798
20.

Transgenic mice as a model of pre-clinical Alzheimer's disease.

Ferretti MT, Partridge V, Leon WC, Canneva F, Allard S, Arvanitis DN, Vercauteren F, Houle D, Ducatenzeiler A, Klein WL, Glabe CG, Szyf M, Cuello AC.

Curr Alzheimer Res. 2011 Feb;8(1):4-23.

PMID:
21143159
21.

Early-stage inflammation and experimental therapy in transgenic models of the Alzheimer-like amyloid pathology.

Cuello AC, Ferretti MT, Leon WC, Iulita MF, Melis T, Ducatenzeiler A, Bruno MA, Canneva F.

Neurodegener Dis. 2010;7(1-3):96-8. doi: 10.1159/000285514. Epub 2010 Feb 18.

PMID:
20173335
22.

A novel transgenic rat model with a full Alzheimer's-like amyloid pathology displays pre-plaque intracellular amyloid-beta-associated cognitive impairment.

Leon WC, Canneva F, Partridge V, Allard S, Ferretti MT, DeWilde A, Vercauteren F, Atifeh R, Ducatenzeiler A, Klein W, Szyf M, Alhonen L, Cuello AC.

J Alzheimers Dis. 2010;20(1):113-26. doi: 10.3233/JAD-2010-1349.

PMID:
20164597
23.

Functional mapping of the promoter region of the GNB2L1 human gene coding for RACK1 scaffold protein.

Del Vecchio I, Zuccotti A, Pisano F, Canneva F, Lenzken SC, Rousset F, Corsini E, Govoni S, Racchi M.

Gene. 2009 Feb 1;430(1-2):17-29. doi: 10.1016/j.gene.2008.10.005. Epub 2008 Oct 21.

PMID:
19000751
24.

Impact of intracellular beta-amyloid in transgenic animals and cell models.

Cuello AC, Canneva F.

Neurodegener Dis. 2008;5(3-4):146-8. doi: 10.1159/000113686. Epub 2008 Mar 6. Review.

PMID:
18322374
25.

Development of the first Gateway firefly luciferase vector and use of reverse transcriptase in FLOE (Fluorescently Labeled Oligonucleotide Extension) reactions.

Del Vecchio I, Zuccotti A, Canneva F, Lenzken SC, Racchi M.

Plasmid. 2007 Nov;58(3):269-74. Epub 2007 Aug 20. Erratum in: Plasmid.2011 Sep;66(3):186.

PMID:
17707908
26.

Rv2358 and FurB: two transcriptional regulators from Mycobacterium tuberculosis which respond to zinc.

Canneva F, Branzoni M, Riccardi G, Provvedi R, Milano A.

J Bacteriol. 2005 Aug;187(16):5837-40. Erratum in: J Bacteriol. 2007 Mar;189(6):2582.

27.

The Mycobacterium tuberculosis Rv2358-furB operon is induced by zinc.

Milano A, Branzoni M, Canneva F, Profumo A, Riccardi G.

Res Microbiol. 2004 Apr;155(3):192-200.

PMID:
15059632
28.

Mycobacterium tuberculosis FurA autoregulates its own expression.

Sala C, Forti F, Di Florio E, Canneva F, Milano A, Riccardi G, Ghisotti D.

J Bacteriol. 2003 Sep;185(18):5357-62.

29.

Expression, purification, and structural characterization of human histone H4.

Vergani L, Canneva F, Ghisellini P, Nicolini C.

Protein Expr Purif. 2002 Apr;24(3):420-8.

PMID:
11922758

Supplemental Content

Loading ...
Support Center